Author

P. Scaffidi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:whole-exome sequencing· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Research Focus:variant calling· 1

Frequent Co-Authors

A. Agraz-Doblas· 1 shared A. Astudillo· 1 shared B. Casar· 1 shared B. Monterde· 1 shared C. Morales Torres· 1 shared C. Revilla· 1 shared C. Yau· 1 shared D. Temelkovski· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Agraz-Doblas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to PARP inhibition in lung cancer

T. Moreno, L. Gonzalez-Silva, B. Monterde, I. Betancor-Fernandez, C. Revilla, A. Agraz-Doblas, J. Freire, P. Isidro, L. Quevedo, S. Montes-Moreno, L. Cereceda, A. Astudillo, B. Casar, P. Crespo, C. Morales Torres, , I. Varela

This study identifies ARID2 deficiency in 20% of lung cancer patients, showing it promotes tumor progression and increases sensitivity to PARP inhibition.

bioRxiv · Jan 10, 2020Cancer Biology

Patient-specific detection of cancer genes reveals recurrently perturbed processes in esophageal adenocarcinoma

T. Mourikis, L. Benedetti, E. Foxall, D. Temelkovski, J. Nulsen, J. Perner, M. Cereda, J. Lagergren, M. Howell, C. Yau, R. Fitzgerald, P. Scaffidi, F. D. Ciccarelli

This study identifies patient-specific cancer genes in esophageal adenocarcinoma using machine learning, revealing recurrent process perturbations that suggest therapeutic targets.

bioRxiv · Oct 17, 2018 · PreprintCancer Biology